146 related articles for article (PubMed ID: 10190891)
1. TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation.
Green EA; Flavell RA
J Exp Med; 1999 Apr; 189(7):1017-20. PubMed ID: 10190891
[No Abstract] [Full Text] [Related]
2. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation.
Bachmann MF; Wong BR; Josien R; Steinman RM; Oxenius A; Choi Y
J Exp Med; 1999 Apr; 189(7):1025-31. PubMed ID: 10190893
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
Williamson E; Bilsborough JM; Viney JL
J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
[TBL] [Abstract][Full Text] [Related]
4. TRANCE together with IL-7 induces pre-B cells to proliferate.
Kato I; Sato H; Kudo A
Eur J Immunol; 2003 Feb; 33(2):334-41. PubMed ID: 12548564
[TBL] [Abstract][Full Text] [Related]
5. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
Kong YY; Yoshida H; Sarosi I; Tan HL; Timms E; Capparelli C; Morony S; Oliveira-dos-Santos AJ; Van G; Itie A; Khoo W; Wakeham A; Dunstan CR; Lacey DL; Mak TW; Boyle WJ; Penninger JM
Nature; 1999 Jan; 397(6717):315-23. PubMed ID: 9950424
[TBL] [Abstract][Full Text] [Related]
6. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R
J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743
[TBL] [Abstract][Full Text] [Related]
7. RANK is essential for osteoclast and lymph node development.
Dougall WC; Glaccum M; Charrier K; Rohrbach K; Brasel K; De Smedt T; Daro E; Smith J; Tometsko ME; Maliszewski CR; Armstrong A; Shen V; Bain S; Cosman D; Anderson D; Morrissey PJ; Peschon JJ; Schuh J
Genes Dev; 1999 Sep; 13(18):2412-24. PubMed ID: 10500098
[TBL] [Abstract][Full Text] [Related]
8. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
Padigel UM; Kim N; Choi Y; Farrell JP
J Immunol; 2003 Nov; 171(10):5437-41. PubMed ID: 14607948
[TBL] [Abstract][Full Text] [Related]
9. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.
Josien R; Wong BR; Li HL; Steinman RM; Choi Y
J Immunol; 1999 Mar; 162(5):2562-8. PubMed ID: 10072496
[TBL] [Abstract][Full Text] [Related]
10. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.
Wong BR; Rho J; Arron J; Robinson E; Orlinick J; Chao M; Kalachikov S; Cayani E; Bartlett FS; Frankel WN; Lee SY; Choi Y
J Biol Chem; 1997 Oct; 272(40):25190-4. PubMed ID: 9312132
[TBL] [Abstract][Full Text] [Related]
11. CD40-CD154 interactions in B-cell signaling.
Calderhead DM; Kosaka Y; Manning EM; Noelle RJ
Curr Top Microbiol Immunol; 2000; 245(2):73-99. PubMed ID: 10533319
[No Abstract] [Full Text] [Related]
12. Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus.
Ikeda T; Kasai M; Utsuyama M; Hirokawa K
Endocrinology; 2001 Apr; 142(4):1419-26. PubMed ID: 11250921
[TBL] [Abstract][Full Text] [Related]
13. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches.
Tsuji M; Komatsu N; Kawamoto S; Suzuki K; Kanagawa O; Honjo T; Hori S; Fagarasan S
Science; 2009 Mar; 323(5920):1488-92. PubMed ID: 19286559
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of mucosal surface IgA+ B cells by Ig receptor cross-linking and CD40 ligand.
Ehrhardt RO; Gray B; Duchmann R; Inman JK; Strober W
J Immunol; 1996 Aug; 157(4):1397-405. PubMed ID: 8759719
[TBL] [Abstract][Full Text] [Related]
15. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson DM; Maraskovsky E; Billingsley WL; Dougall WC; Tometsko ME; Roux ER; Teepe MC; DuBose RF; Cosman D; Galibert L
Nature; 1997 Nov; 390(6656):175-9. PubMed ID: 9367155
[TBL] [Abstract][Full Text] [Related]
16. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
Takahashi N; Udagawa N; Suda T
Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development.
Kong YY; Boyle WJ; Penninger JM
Immunol Cell Biol; 1999 Apr; 77(2):188-93. PubMed ID: 10234557
[TBL] [Abstract][Full Text] [Related]
18. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.
Pasparakis M; Alexopoulou L; Grell M; Pfizenmaier K; Bluethmann H; Kollias G
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6319-23. PubMed ID: 9177215
[TBL] [Abstract][Full Text] [Related]
19. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo.
Josien R; Li HL; Ingulli E; Sarma S; Wong BR; Vologodskaia M; Steinman RM; Choi Y
J Exp Med; 2000 Feb; 191(3):495-502. PubMed ID: 10662795
[TBL] [Abstract][Full Text] [Related]
20. An essential role for gp39, the ligand for CD40, in thymic selection.
Foy TM; Page DM; Waldschmidt TJ; Schoneveld A; Laman JD; Masters SR; Tygrett L; Ledbetter JA; Aruffo A; Claassen E; Xu JC; Flavell RA; Oehen S; Hedrick SM; Noelle RJ
J Exp Med; 1995 Nov; 182(5):1377-88. PubMed ID: 7595208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
